Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old (any gender).
- You have been diagnosed with pancreatic cancer confirmed by a tissue sample (biopsy), and your cancer falls into one of three categories: high-risk but potentially removable by surgery, borderline removable by surgery, or locally advanced (not yet spread to distant parts of the body).
- Your cancer has been reviewed by a team of specialists who agree that treatment before surgery (neoadjuvant therapy) is appropriate for you.
- You are generally well enough to carry out light activity and care for yourself (a standard health score of 0 or 1 on a common medical scale).
- Your doctors estimate you are likely to live at least 6 months.
- Your heart, liver, and kidneys are working well enough, based on recent blood tests showing liver and kidney values within an acceptable range.
- You are willing and able to sign a consent form agreeing to take part.
Who may not be able to join:
- Your cancer has already spread to distant parts of your body (such as other organs).
- You have previously had any cancer treatment, including chemotherapy, radiation, immunotherapy, targeted therapy, or certain traditional Chinese medicine anti-cancer treatments.
- You currently have another active cancer.
- You are pregnant or breastfeeding.
- You have had a serious allergic reaction to any of the drugs used in the standard treatment plan for this type of cancer.
- You have previously had a stem cell transplant or an organ transplant.
- You have a condition that weakens your immune system, including HIV infection, active Hepatitis B, active Hepatitis C, or a combination of these infections (confirm with trial site for full details on immune conditions).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 021-64370045-678805
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The correlation between ctDNA-MRD status at serial monitoring points during neoadjuvant therapy and therapeutic efficacy (R0 resection).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.